HomeOwner Search
Visit USCO2013
Category SearchDeveloping Thyronamine Analog Pharmaceuticals Targeting TAAR1 to Treat Methamphetamine Addiction
Text Registration
Copyright Title
Developing Thyronamine Analog Pharmaceuticals Targeting TAAR1 to Treat Methamphetamine Addiction
Status
Published
on 12 Nov 2013
Year of Creation
2013
Copyright Claimant
Troy Andrew Wahl
Registration Number
TX0006794596
on 12 Nov 2013Copyright Summary
The U.S. Copyright record (Registration Number: TX0006794596) dated 12 Nov 2013, pertains to an electronic file (eService) titled "Developing Thyronamine Analog Pharmaceuticals Targeting TAAR1 to Treat Methamphetamine Addiction" created in 2013. The copyright holder is Troy Andrew Wahl, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Troy Andrew Wahl.
Application Details
Registration Number
TX0006794596
Registration Date
11/12/2013
Year of Creation
2013
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Computer text data
Notes
Rights Note: Rights and permissions info. on CORDS appl. in CO
Local Copyright Note: Electronic registration
Statements
Author Statement: entire text: Troy Andrew Wahl
© 2023 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.